Ovarian Cancer Research Alliance, along with three leading ovarian cancer organizations, have launched a first-of-its-kind $1 million+ global grant to improve ovarian cancer survival rates as the inaugural action of a new Global Ovarian Cancer Research Consortium. This grant supports international, multidisciplinary research using artificial intelligence (AI) to improve ovarian cancer survival rates. Proposals must include lead investigators from the United States, United Kingdom, Canada, and Australia, and must demonstrate significant AI integration. The successful grant will support any area of research that will improve survival rates and must have a multi-jurisdictional team from across the grant-funded countries, as well as a multi-disciplinary team, including an AI expert. Clinical expertise is strongly preferred. Research may focus on areas such as early detection, treatment response, recurrence monitoring, and prevention. Support of up to $1 million USD to be used over 3 years, will be awarded to the institution of the Principal Investigator. Microsoft is generously partnering on this grant to donate up to $1 million of in-kind Azure compute credits to the successful project through Microsoft’s AI for Good Lab-partnership with OCRA.
In partnership with the Global Ovarian Cancer Research Consortium and Microsoft’s AI for Good Lab
